113 related articles for article (PubMed ID: 17969887)
21. [Comparative study on therapeutic effects of gandou tablet I and dimercaptosuccinate acid in treating Wilson disease].
Han Y; He G; Wang X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Feb; 19(2):69-70. PubMed ID: 11783297
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
23. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
[TBL] [Abstract][Full Text] [Related]
24. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
Zheng M; Cai W; Weng H; Liu R
Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
[TBL] [Abstract][Full Text] [Related]
25. [Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule].
Chen H; Weng L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr; 20(4):255-7. PubMed ID: 11789260
[TBL] [Abstract][Full Text] [Related]
26. [Corbrin shugan capsule for treatment of alcoholic hepatic fibrosis in rats].
Hu R; Fu XC; Shen LM; Bai HB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):564-8. PubMed ID: 23086651
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study on treatment of liver fibrosis in patients of hepatitis B by kangxian baogan decoction].
Liang TJ; Zhang W; Zhang CQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):332-4. PubMed ID: 12584827
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic effect of Hongbeiyegen on alcohol-induced rat hepatic fibrosis].
Lü XY; Liu Q; Chen YY; Song YH; Lü ZP
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):153-5. PubMed ID: 17355923
[TBL] [Abstract][Full Text] [Related]
29. [Comparative study of the clinical effects of salvia miltiorrhiza injection and shengmai injection on chronic hepatitis B].
Jin CX; Yang J; Sun HF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):936-8. PubMed ID: 17121050
[TBL] [Abstract][Full Text] [Related]
30. Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling.
Gao J; Feng LJ; Huang Y; Li P; Xu DJ; Li J; Wu Q
J Pharm Pharmacol; 2012 Jun; 64(6):811-20. PubMed ID: 22571259
[TBL] [Abstract][Full Text] [Related]
31. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
32. [Observation on dynamic changes of serum procollagen III, hyaluronic acid and laminin in rats with hepatic fibrosis treated with Hujin pill].
Huang Z; Li Q; Wang Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jun; 20(6):447-9. PubMed ID: 11789232
[TBL] [Abstract][Full Text] [Related]
33. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
Hu YY; Liu P; Liu C
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):18-22. PubMed ID: 16466166
[TBL] [Abstract][Full Text] [Related]
34. [The relationship between TGFbeta1 and TIMP-1 and its effects on the diagnosis of hepatic fibrosis].
Zhang LF; Tian XX; Wang CF
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):258-60. PubMed ID: 17456311
[TBL] [Abstract][Full Text] [Related]
35. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
Sun W; Gui S; Wu L; Wang H; Wei W
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
[TBL] [Abstract][Full Text] [Related]
36. [Determination and significance of serum markers for fibrosis in patients with chronic hepatitis].
Cai W; Zheng M; Weng H; Liu R
Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):448-51. PubMed ID: 11798612
[TBL] [Abstract][Full Text] [Related]
37. Influence factors of serum fibrosis markers in liver fibrosis.
Tao J; Peng HQ; Cai WM; Dong FQ; Weng HL; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2497-500. PubMed ID: 14606083
[TBL] [Abstract][Full Text] [Related]
38. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study].
Liu SY; Zhang YQ; Liu YL; Guo P; Zhou CM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1457-61. PubMed ID: 24483103
[TBL] [Abstract][Full Text] [Related]
39. Haemolysis during sodium dimercaptosulphonate therapy for Wilson's disease in G6PD-deficient patients: First report of two cases.
Lai S; Huang YQ; Liu AQ; Wu HW
J Clin Pharm Ther; 2017 Dec; 42(6):783-785. PubMed ID: 28635014
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
